nodes	percent_of_prediction	percent_of_DWPC	metapath
Eprosartan—ABCC2—Sulfasalazine—ulcerative colitis	0.207	0.402	CbGbCtD
Eprosartan—ABCC2—Dexamethasone—ulcerative colitis	0.103	0.201	CbGbCtD
Eprosartan—CYP2C9—Nicotine—ulcerative colitis	0.0894	0.174	CbGbCtD
Eprosartan—CYP2C9—Cholecalciferol—ulcerative colitis	0.0801	0.156	CbGbCtD
Eprosartan—ABCC2—bile duct—ulcerative colitis	0.0357	0.397	CbGeAlD
Eprosartan—CYP2C9—Dexamethasone—ulcerative colitis	0.0347	0.0674	CbGbCtD
Eprosartan—ABCC2—bile—ulcerative colitis	0.0274	0.305	CbGeAlD
Eprosartan—AGTR1—epithelium—ulcerative colitis	0.00544	0.0607	CbGeAlD
Eprosartan—AGTR1—smooth muscle tissue—ulcerative colitis	0.00524	0.0585	CbGeAlD
Eprosartan—AGTR1—lymphoid tissue—ulcerative colitis	0.00419	0.0467	CbGeAlD
Eprosartan—AGTR1—Allograft Rejection—MICA—ulcerative colitis	0.00384	0.0683	CbGpPWpGaD
Eprosartan—AGTR1—liver—ulcerative colitis	0.00308	0.0344	CbGeAlD
Eprosartan—ABCC2—digestive system—ulcerative colitis	0.00299	0.0334	CbGeAlD
Eprosartan—ABCC2—Codeine and Morphine Metabolism—ABCB1—ulcerative colitis	0.00282	0.0501	CbGpPWpGaD
Eprosartan—ABCC2—liver—ulcerative colitis	0.00223	0.0249	CbGeAlD
Eprosartan—CYP2C9—digestive system—ulcerative colitis	0.00199	0.0222	CbGeAlD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—GPR35—ulcerative colitis	0.00175	0.0311	CbGpPWpGaD
Eprosartan—ABCC2—NRF2 pathway—SLC39A11—ulcerative colitis	0.00173	0.0307	CbGpPWpGaD
Eprosartan—AGTR1—Peptide GPCRs—CXCR1—ulcerative colitis	0.00171	0.0303	CbGpPWpGaD
Eprosartan—ABCC2—Drug Induction of Bile Acid Pathway—ABCB1—ulcerative colitis	0.00154	0.0274	CbGpPWpGaD
Eprosartan—ABCC2—Drug Induction of Bile Acid Pathway—VDR—ulcerative colitis	0.00154	0.0274	CbGpPWpGaD
Eprosartan—AGTR1—Arf6 signaling events—ADRB2—ulcerative colitis	0.00152	0.0271	CbGpPWpGaD
Eprosartan—CYP2C9—liver—ulcerative colitis	0.00149	0.0166	CbGeAlD
Eprosartan—AGTR1—Peptide GPCRs—CXCR2—ulcerative colitis	0.00134	0.0237	CbGpPWpGaD
Eprosartan—AGTR1—Peptide GPCRs—CCR6—ulcerative colitis	0.00126	0.0223	CbGpPWpGaD
Eprosartan—AGTR1—Arf6 trafficking events—ADRB2—ulcerative colitis	0.0012	0.0214	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—IL17A—ulcerative colitis	0.00103	0.0184	CbGpPWpGaD
Eprosartan—AGTR1—ACE Inhibitor Pathway—TGFB1—ulcerative colitis	0.000978	0.0174	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—IL12B—ulcerative colitis	0.000961	0.0171	CbGpPWpGaD
Eprosartan—Losartan—ALB—ulcerative colitis	0.00095	0.512	CrCbGaD
Eprosartan—ABCC2—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	0.000931	0.0165	CbGpPWpGaD
Eprosartan—Losartan—ABCB1—ulcerative colitis	0.000906	0.488	CrCbGaD
Eprosartan—AGTR1—Allograft Rejection—CTLA4—ulcerative colitis	0.000903	0.016	CbGpPWpGaD
Eprosartan—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	0.000886	0.0157	CbGpPWpGaD
Eprosartan—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	0.000885	0.0157	CbGpPWpGaD
Eprosartan—ABCC2—ABC-family proteins mediated transport—ABCB1—ulcerative colitis	0.000847	0.015	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—CXCR1—ulcerative colitis	0.000803	0.0143	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—HLA-DQA1—ulcerative colitis	0.000795	0.0141	CbGpPWpGaD
Eprosartan—AGTR1—Arf6 trafficking events—CDH1—ulcerative colitis	0.000727	0.0129	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—ABCB1—ulcerative colitis	0.000723	0.0129	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—CCL20—ulcerative colitis	0.000705	0.0125	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—IL10—ulcerative colitis	0.000702	0.0125	CbGpPWpGaD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—CXCR1—ulcerative colitis	0.000628	0.0112	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—CXCR2—ulcerative colitis	0.000628	0.0112	CbGpPWpGaD
Eprosartan—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	0.000617	0.011	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—CCR6—ulcerative colitis	0.000591	0.0105	CbGpPWpGaD
Eprosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—RELA—ulcerative colitis	0.000588	0.0104	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—HLA-DRB1—ulcerative colitis	0.000565	0.01	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCR1—ulcerative colitis	0.000538	0.00957	CbGpPWpGaD
Eprosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—NFKB1—ulcerative colitis	0.000495	0.0088	CbGpPWpGaD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—CXCR2—ulcerative colitis	0.000492	0.00874	CbGpPWpGaD
Eprosartan—AGTR1—G alpha (q) signalling events—GHRL—ulcerative colitis	0.000482	0.00857	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—GHRL—ulcerative colitis	0.000476	0.00846	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL20—ulcerative colitis	0.000473	0.0084	CbGpPWpGaD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—CCR6—ulcerative colitis	0.000462	0.00821	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—ulcerative colitis	0.000431	0.00766	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCR2—ulcerative colitis	0.000421	0.00748	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	0.000419	0.00744	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—IFNG—ulcerative colitis	0.000413	0.00734	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—CXCR1—ulcerative colitis	0.00041	0.00728	CbGpPWpGaD
Eprosartan—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	0.000409	0.00726	CbGpPWpGaD
Eprosartan—CYP2C9—Arachidonic acid metabolism—PTGS1—ulcerative colitis	0.000408	0.00726	CbGpPWpGaD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—PTGER4—ulcerative colitis	0.000407	0.00723	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCR6—ulcerative colitis	0.000396	0.00704	CbGpPWpGaD
Eprosartan—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	0.000389	0.00692	CbGpPWpGaD
Eprosartan—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	0.000389	0.0069	CbGpPWpGaD
Eprosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—TNF—ulcerative colitis	0.000385	0.00685	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—CXCL8—ulcerative colitis	0.000384	0.00682	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—IL1B—ulcerative colitis	0.000368	0.00654	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—IL2—ulcerative colitis	0.000367	0.00652	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—CCL20—ulcerative colitis	0.00036	0.00639	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—PTGER4—ulcerative colitis	0.000349	0.0062	CbGpPWpGaD
Eprosartan—Urticaria—Mesalazine—ulcerative colitis	0.000337	0.000999	CcSEcCtD
Eprosartan—Back pain—Triamcinolone—ulcerative colitis	0.000337	0.000998	CcSEcCtD
Eprosartan—Body temperature increased—Mesalazine—ulcerative colitis	0.000336	0.000994	CcSEcCtD
Eprosartan—Abdominal pain—Mesalazine—ulcerative colitis	0.000336	0.000994	CcSEcCtD
Eprosartan—Malaise—Hydrocortisone—ulcerative colitis	0.000334	0.000988	CcSEcCtD
Eprosartan—Loss of consciousness—Prednisolone—ulcerative colitis	0.000333	0.000986	CcSEcCtD
Eprosartan—Vertigo—Hydrocortisone—ulcerative colitis	0.000333	0.000984	CcSEcCtD
Eprosartan—Vomiting—Budesonide—ulcerative colitis	0.000332	0.000983	CcSEcCtD
Eprosartan—Syncope—Hydrocortisone—ulcerative colitis	0.000332	0.000982	CcSEcCtD
Eprosartan—Rash—Budesonide—ulcerative colitis	0.000329	0.000975	CcSEcCtD
Eprosartan—Dermatitis—Budesonide—ulcerative colitis	0.000329	0.000974	CcSEcCtD
Eprosartan—Headache—Budesonide—ulcerative colitis	0.000327	0.000968	CcSEcCtD
Eprosartan—Loss of consciousness—Hydrocortisone—ulcerative colitis	0.000325	0.000963	CcSEcCtD
Eprosartan—Ill-defined disorder—Triamcinolone—ulcerative colitis	0.000323	0.000957	CcSEcCtD
Eprosartan—Ill-defined disorder—Methylprednisolone—ulcerative colitis	0.000323	0.000955	CcSEcCtD
Eprosartan—Bradycardia—Prednisone—ulcerative colitis	0.000322	0.000953	CcSEcCtD
Eprosartan—AGTR1—GPCR ligand binding—CXCR2—ulcerative colitis	0.000321	0.0057	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	0.000319	0.00567	CbGpPWpGaD
Eprosartan—Diarrhoea—Azathioprine—ulcerative colitis	0.000319	0.000944	CcSEcCtD
Eprosartan—Discomfort—Prednisolone—ulcerative colitis	0.000319	0.000943	CcSEcCtD
Eprosartan—Angioedema—Triamcinolone—ulcerative colitis	0.000318	0.000942	CcSEcCtD
Eprosartan—Angioedema—Methylprednisolone—ulcerative colitis	0.000318	0.00094	CcSEcCtD
Eprosartan—Myalgia—Hydrocortisone—ulcerative colitis	0.000315	0.000932	CcSEcCtD
Eprosartan—Malaise—Triamcinolone—ulcerative colitis	0.000314	0.00093	CcSEcCtD
Eprosartan—Anxiety—Hydrocortisone—ulcerative colitis	0.000314	0.000929	CcSEcCtD
Eprosartan—Malaise—Methylprednisolone—ulcerative colitis	0.000314	0.000928	CcSEcCtD
Eprosartan—Vertigo—Triamcinolone—ulcerative colitis	0.000313	0.000927	CcSEcCtD
Eprosartan—Hypersensitivity—Mesalazine—ulcerative colitis	0.000313	0.000926	CcSEcCtD
Eprosartan—Syncope—Triamcinolone—ulcerative colitis	0.000313	0.000925	CcSEcCtD
Eprosartan—Vertigo—Methylprednisolone—ulcerative colitis	0.000312	0.000925	CcSEcCtD
Eprosartan—Syncope—Methylprednisolone—ulcerative colitis	0.000312	0.000923	CcSEcCtD
Eprosartan—Discomfort—Hydrocortisone—ulcerative colitis	0.000311	0.000921	CcSEcCtD
Eprosartan—Nausea—Budesonide—ulcerative colitis	0.00031	0.000918	CcSEcCtD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—ADRB2—ulcerative colitis	0.000308	0.00548	CbGpPWpGaD
Eprosartan—Dizziness—Azathioprine—ulcerative colitis	0.000308	0.000913	CcSEcCtD
Eprosartan—Loss of consciousness—Triamcinolone—ulcerative colitis	0.000306	0.000906	CcSEcCtD
Eprosartan—Loss of consciousness—Methylprednisolone—ulcerative colitis	0.000306	0.000904	CcSEcCtD
Eprosartan—Asthenia—Mesalazine—ulcerative colitis	0.000305	0.000902	CcSEcCtD
Eprosartan—Shock—Prednisolone—ulcerative colitis	0.000304	0.0009	CcSEcCtD
Eprosartan—Cough—Triamcinolone—ulcerative colitis	0.000304	0.0009	CcSEcCtD
Eprosartan—Tachycardia—Prednisolone—ulcerative colitis	0.000302	0.000893	CcSEcCtD
Eprosartan—AGTR1—GPCR ligand binding—CCR6—ulcerative colitis	0.000302	0.00536	CbGpPWpGaD
Eprosartan—Pruritus—Mesalazine—ulcerative colitis	0.000301	0.000889	CcSEcCtD
Eprosartan—Hyperhidrosis—Prednisolone—ulcerative colitis	0.000299	0.000885	CcSEcCtD
Eprosartan—Shock—Hydrocortisone—ulcerative colitis	0.000297	0.000879	CcSEcCtD
Eprosartan—Myalgia—Triamcinolone—ulcerative colitis	0.000297	0.000878	CcSEcCtD
Eprosartan—Vomiting—Azathioprine—ulcerative colitis	0.000297	0.000877	CcSEcCtD
Eprosartan—Myalgia—Methylprednisolone—ulcerative colitis	0.000296	0.000876	CcSEcCtD
Eprosartan—Arthralgia—Methylprednisolone—ulcerative colitis	0.000296	0.000876	CcSEcCtD
Eprosartan—Anxiety—Methylprednisolone—ulcerative colitis	0.000295	0.000873	CcSEcCtD
Eprosartan—Tachycardia—Hydrocortisone—ulcerative colitis	0.000295	0.000872	CcSEcCtD
Eprosartan—Rash—Azathioprine—ulcerative colitis	0.000294	0.00087	CcSEcCtD
Eprosartan—Dermatitis—Azathioprine—ulcerative colitis	0.000294	0.000869	CcSEcCtD
Eprosartan—Ill-defined disorder—Dexamethasone—ulcerative colitis	0.000293	0.000868	CcSEcCtD
Eprosartan—Ill-defined disorder—Betamethasone—ulcerative colitis	0.000293	0.000868	CcSEcCtD
Eprosartan—Discomfort—Triamcinolone—ulcerative colitis	0.000293	0.000867	CcSEcCtD
Eprosartan—Discomfort—Methylprednisolone—ulcerative colitis	0.000292	0.000866	CcSEcCtD
Eprosartan—Headache—Azathioprine—ulcerative colitis	0.000292	0.000865	CcSEcCtD
Eprosartan—Hyperhidrosis—Hydrocortisone—ulcerative colitis	0.000292	0.000864	CcSEcCtD
Eprosartan—Diarrhoea—Mesalazine—ulcerative colitis	0.000291	0.00086	CcSEcCtD
Eprosartan—Dry mouth—Triamcinolone—ulcerative colitis	0.00029	0.000859	CcSEcCtD
Eprosartan—Angioedema—Dexamethasone—ulcerative colitis	0.000289	0.000855	CcSEcCtD
Eprosartan—Angioedema—Betamethasone—ulcerative colitis	0.000289	0.000855	CcSEcCtD
Eprosartan—Anorexia—Hydrocortisone—ulcerative colitis	0.000288	0.000852	CcSEcCtD
Eprosartan—AGTR1—Allograft Rejection—TGFB1—ulcerative colitis	0.000286	0.00509	CbGpPWpGaD
Eprosartan—CYP2C9—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	0.000286	0.00508	CbGpPWpGaD
Eprosartan—Malaise—Dexamethasone—ulcerative colitis	0.000285	0.000844	CcSEcCtD
Eprosartan—Malaise—Betamethasone—ulcerative colitis	0.000285	0.000844	CcSEcCtD
Eprosartan—Vertigo—Betamethasone—ulcerative colitis	0.000284	0.000841	CcSEcCtD
Eprosartan—Vertigo—Dexamethasone—ulcerative colitis	0.000284	0.000841	CcSEcCtD
Eprosartan—Syncope—Dexamethasone—ulcerative colitis	0.000284	0.000839	CcSEcCtD
Eprosartan—Syncope—Betamethasone—ulcerative colitis	0.000284	0.000839	CcSEcCtD
Eprosartan—Hypotension—Hydrocortisone—ulcerative colitis	0.000282	0.000835	CcSEcCtD
Eprosartan—Dizziness—Mesalazine—ulcerative colitis	0.000281	0.000831	CcSEcCtD
Eprosartan—Shock—Triamcinolone—ulcerative colitis	0.00028	0.000828	CcSEcCtD
Eprosartan—Insomnia—Prednisolone—ulcerative colitis	0.00028	0.000828	CcSEcCtD
Eprosartan—Shock—Methylprednisolone—ulcerative colitis	0.000279	0.000826	CcSEcCtD
Eprosartan—Loss of consciousness—Dexamethasone—ulcerative colitis	0.000278	0.000822	CcSEcCtD
Eprosartan—Loss of consciousness—Betamethasone—ulcerative colitis	0.000278	0.000822	CcSEcCtD
Eprosartan—Paraesthesia—Prednisolone—ulcerative colitis	0.000278	0.000822	CcSEcCtD
Eprosartan—Tachycardia—Triamcinolone—ulcerative colitis	0.000278	0.000821	CcSEcCtD
Eprosartan—Nausea—Azathioprine—ulcerative colitis	0.000277	0.00082	CcSEcCtD
Eprosartan—Tachycardia—Methylprednisolone—ulcerative colitis	0.000277	0.00082	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	0.000275	0.000814	CcSEcCtD
Eprosartan—Hyperhidrosis—Triamcinolone—ulcerative colitis	0.000275	0.000814	CcSEcCtD
Eprosartan—Hyperhidrosis—Methylprednisolone—ulcerative colitis	0.000274	0.000812	CcSEcCtD
Eprosartan—Insomnia—Hydrocortisone—ulcerative colitis	0.000273	0.000808	CcSEcCtD
Eprosartan—Paraesthesia—Hydrocortisone—ulcerative colitis	0.000271	0.000803	CcSEcCtD
Eprosartan—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	0.000271	0.00481	CbGpPWpGaD
Eprosartan—Vomiting—Mesalazine—ulcerative colitis	0.00027	0.000799	CcSEcCtD
Eprosartan—Myalgia—Dexamethasone—ulcerative colitis	0.000269	0.000797	CcSEcCtD
Eprosartan—Myalgia—Betamethasone—ulcerative colitis	0.000269	0.000797	CcSEcCtD
Eprosartan—Anxiety—Betamethasone—ulcerative colitis	0.000268	0.000794	CcSEcCtD
Eprosartan—Anxiety—Dexamethasone—ulcerative colitis	0.000268	0.000794	CcSEcCtD
Eprosartan—Rash—Mesalazine—ulcerative colitis	0.000268	0.000793	CcSEcCtD
Eprosartan—Dermatitis—Mesalazine—ulcerative colitis	0.000268	0.000792	CcSEcCtD
Eprosartan—AGTR1—Allograft Rejection—TNF—ulcerative colitis	0.000267	0.00475	CbGpPWpGaD
Eprosartan—Headache—Mesalazine—ulcerative colitis	0.000266	0.000788	CcSEcCtD
Eprosartan—Discomfort—Dexamethasone—ulcerative colitis	0.000266	0.000787	CcSEcCtD
Eprosartan—Discomfort—Betamethasone—ulcerative colitis	0.000266	0.000787	CcSEcCtD
Eprosartan—Dyspepsia—Hydrocortisone—ulcerative colitis	0.000266	0.000787	CcSEcCtD
Eprosartan—AGTR1—GPCR ligand binding—PTGER4—ulcerative colitis	0.000266	0.00472	CbGpPWpGaD
Eprosartan—Hypotension—Methylprednisolone—ulcerative colitis	0.000265	0.000785	CcSEcCtD
Eprosartan—Pain—Prednisolone—ulcerative colitis	0.000264	0.000783	CcSEcCtD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	0.000264	0.0047	CbGpPWpGaD
Eprosartan—Decreased appetite—Hydrocortisone—ulcerative colitis	0.000263	0.000777	CcSEcCtD
Eprosartan—Fatigue—Hydrocortisone—ulcerative colitis	0.00026	0.000771	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	0.000259	0.000767	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	0.000259	0.000765	CcSEcCtD
Eprosartan—Pain—Hydrocortisone—ulcerative colitis	0.000258	0.000764	CcSEcCtD
Eprosartan—Insomnia—Triamcinolone—ulcerative colitis	0.000257	0.000761	CcSEcCtD
Eprosartan—Insomnia—Methylprednisolone—ulcerative colitis	0.000257	0.00076	CcSEcCtD
Eprosartan—Ill-defined disorder—Prednisone—ulcerative colitis	0.000256	0.000756	CcSEcCtD
Eprosartan—Paraesthesia—Triamcinolone—ulcerative colitis	0.000255	0.000756	CcSEcCtD
Eprosartan—Feeling abnormal—Prednisolone—ulcerative colitis	0.000255	0.000754	CcSEcCtD
Eprosartan—Paraesthesia—Methylprednisolone—ulcerative colitis	0.000255	0.000754	CcSEcCtD
Eprosartan—Shock—Dexamethasone—ulcerative colitis	0.000254	0.000751	CcSEcCtD
Eprosartan—Shock—Betamethasone—ulcerative colitis	0.000254	0.000751	CcSEcCtD
Eprosartan—Dyspnoea—Triamcinolone—ulcerative colitis	0.000254	0.00075	CcSEcCtD
Eprosartan—Thrombocytopenia—Dexamethasone—ulcerative colitis	0.000253	0.000748	CcSEcCtD
Eprosartan—Thrombocytopenia—Betamethasone—ulcerative colitis	0.000253	0.000748	CcSEcCtD
Eprosartan—Nausea—Mesalazine—ulcerative colitis	0.000252	0.000747	CcSEcCtD
Eprosartan—Tachycardia—Betamethasone—ulcerative colitis	0.000252	0.000745	CcSEcCtD
Eprosartan—Tachycardia—Dexamethasone—ulcerative colitis	0.000252	0.000745	CcSEcCtD
Eprosartan—Angioedema—Prednisone—ulcerative colitis	0.000252	0.000745	CcSEcCtD
Eprosartan—Dyspepsia—Triamcinolone—ulcerative colitis	0.00025	0.000741	CcSEcCtD
Eprosartan—Dyspepsia—Methylprednisolone—ulcerative colitis	0.00025	0.000739	CcSEcCtD
Eprosartan—Hyperhidrosis—Betamethasone—ulcerative colitis	0.000249	0.000738	CcSEcCtD
Eprosartan—Hyperhidrosis—Dexamethasone—ulcerative colitis	0.000249	0.000738	CcSEcCtD
Eprosartan—Feeling abnormal—Hydrocortisone—ulcerative colitis	0.000249	0.000737	CcSEcCtD
Eprosartan—Malaise—Prednisone—ulcerative colitis	0.000248	0.000735	CcSEcCtD
Eprosartan—Vertigo—Prednisone—ulcerative colitis	0.000247	0.000732	CcSEcCtD
Eprosartan—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	0.000247	0.000731	CcSEcCtD
Eprosartan—Syncope—Prednisone—ulcerative colitis	0.000247	0.000731	CcSEcCtD
Eprosartan—ABCC2—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	0.000247	0.00439	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	0.000247	0.00439	CbGpPWpGaD
Eprosartan—Anorexia—Dexamethasone—ulcerative colitis	0.000246	0.000728	CcSEcCtD
Eprosartan—Anorexia—Betamethasone—ulcerative colitis	0.000246	0.000728	CcSEcCtD
Eprosartan—Urticaria—Prednisolone—ulcerative colitis	0.000246	0.000727	CcSEcCtD
Eprosartan—Fatigue—Triamcinolone—ulcerative colitis	0.000245	0.000726	CcSEcCtD
Eprosartan—Fatigue—Methylprednisolone—ulcerative colitis	0.000245	0.000724	CcSEcCtD
Eprosartan—Pain—Triamcinolone—ulcerative colitis	0.000243	0.00072	CcSEcCtD
Eprosartan—AGTR1—GPCR ligand binding—GHRL—ulcerative colitis	0.000243	0.00432	CbGpPWpGaD
Eprosartan—Loss of consciousness—Prednisone—ulcerative colitis	0.000242	0.000716	CcSEcCtD
Eprosartan—Hypotension—Betamethasone—ulcerative colitis	0.000241	0.000714	CcSEcCtD
Eprosartan—Hypotension—Dexamethasone—ulcerative colitis	0.000241	0.000714	CcSEcCtD
Eprosartan—Urticaria—Hydrocortisone—ulcerative colitis	0.00024	0.00071	CcSEcCtD
Eprosartan—Body temperature increased—Hydrocortisone—ulcerative colitis	0.000239	0.000707	CcSEcCtD
Eprosartan—Abdominal pain—Hydrocortisone—ulcerative colitis	0.000239	0.000707	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	0.000235	0.000696	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	0.000235	0.000696	CcSEcCtD
Eprosartan—Myalgia—Prednisone—ulcerative colitis	0.000234	0.000694	CcSEcCtD
Eprosartan—Arthralgia—Prednisone—ulcerative colitis	0.000234	0.000694	CcSEcCtD
Eprosartan—Feeling abnormal—Triamcinolone—ulcerative colitis	0.000234	0.000694	CcSEcCtD
Eprosartan—Feeling abnormal—Methylprednisolone—ulcerative colitis	0.000234	0.000692	CcSEcCtD
Eprosartan—Anxiety—Prednisone—ulcerative colitis	0.000234	0.000691	CcSEcCtD
Eprosartan—Insomnia—Dexamethasone—ulcerative colitis	0.000233	0.000691	CcSEcCtD
Eprosartan—Insomnia—Betamethasone—ulcerative colitis	0.000233	0.000691	CcSEcCtD
Eprosartan—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	0.000232	0.000687	CcSEcCtD
Eprosartan—Paraesthesia—Dexamethasone—ulcerative colitis	0.000232	0.000686	CcSEcCtD
Eprosartan—Paraesthesia—Betamethasone—ulcerative colitis	0.000232	0.000686	CcSEcCtD
Eprosartan—AGTR1—GPCR downstream signaling—CXCR1—ulcerative colitis	0.000232	0.00412	CbGpPWpGaD
Eprosartan—Discomfort—Prednisone—ulcerative colitis	0.000232	0.000685	CcSEcCtD
Eprosartan—Hypersensitivity—Prednisolone—ulcerative colitis	0.000228	0.000674	CcSEcCtD
Eprosartan—Dyspepsia—Betamethasone—ulcerative colitis	0.000227	0.000672	CcSEcCtD
Eprosartan—Dyspepsia—Dexamethasone—ulcerative colitis	0.000227	0.000672	CcSEcCtD
Eprosartan—Urticaria—Triamcinolone—ulcerative colitis	0.000226	0.000669	CcSEcCtD
Eprosartan—Urticaria—Methylprednisolone—ulcerative colitis	0.000225	0.000667	CcSEcCtD
Eprosartan—Body temperature increased—Triamcinolone—ulcerative colitis	0.000225	0.000665	CcSEcCtD
Eprosartan—Abdominal pain—Methylprednisolone—ulcerative colitis	0.000224	0.000664	CcSEcCtD
Eprosartan—Decreased appetite—Dexamethasone—ulcerative colitis	0.000224	0.000664	CcSEcCtD
Eprosartan—Decreased appetite—Betamethasone—ulcerative colitis	0.000224	0.000664	CcSEcCtD
Eprosartan—Hypersensitivity—Hydrocortisone—ulcerative colitis	0.000223	0.000659	CcSEcCtD
Eprosartan—Fatigue—Betamethasone—ulcerative colitis	0.000223	0.000658	CcSEcCtD
Eprosartan—Fatigue—Dexamethasone—ulcerative colitis	0.000223	0.000658	CcSEcCtD
Eprosartan—Shock—Prednisone—ulcerative colitis	0.000221	0.000654	CcSEcCtD
Eprosartan—Pain—Dexamethasone—ulcerative colitis	0.000221	0.000653	CcSEcCtD
Eprosartan—Pain—Betamethasone—ulcerative colitis	0.000221	0.000653	CcSEcCtD
Eprosartan—Tachycardia—Prednisone—ulcerative colitis	0.000219	0.000649	CcSEcCtD
Eprosartan—Hyperhidrosis—Prednisone—ulcerative colitis	0.000217	0.000643	CcSEcCtD
Eprosartan—Asthenia—Hydrocortisone—ulcerative colitis	0.000217	0.000641	CcSEcCtD
Eprosartan—Anorexia—Prednisone—ulcerative colitis	0.000214	0.000634	CcSEcCtD
Eprosartan—Pruritus—Hydrocortisone—ulcerative colitis	0.000214	0.000632	CcSEcCtD
Eprosartan—Feeling abnormal—Dexamethasone—ulcerative colitis	0.000213	0.000629	CcSEcCtD
Eprosartan—Feeling abnormal—Betamethasone—ulcerative colitis	0.000213	0.000629	CcSEcCtD
Eprosartan—Gastrointestinal pain—Betamethasone—ulcerative colitis	0.000211	0.000625	CcSEcCtD
Eprosartan—Gastrointestinal pain—Dexamethasone—ulcerative colitis	0.000211	0.000625	CcSEcCtD
Eprosartan—AGTR1—Signaling by GPCR—CXCR1—ulcerative colitis	0.00021	0.00374	CbGpPWpGaD
Eprosartan—Hypersensitivity—Triamcinolone—ulcerative colitis	0.00021	0.00062	CcSEcCtD
Eprosartan—Hypersensitivity—Methylprednisolone—ulcerative colitis	0.000209	0.000619	CcSEcCtD
Eprosartan—Diarrhoea—Hydrocortisone—ulcerative colitis	0.000207	0.000612	CcSEcCtD
Eprosartan—Urticaria—Dexamethasone—ulcerative colitis	0.000205	0.000607	CcSEcCtD
Eprosartan—Urticaria—Betamethasone—ulcerative colitis	0.000205	0.000607	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Prednisone—ulcerative colitis	0.000205	0.000606	CcSEcCtD
Eprosartan—Dizziness—Prednisolone—ulcerative colitis	0.000205	0.000605	CcSEcCtD
Eprosartan—Asthenia—Triamcinolone—ulcerative colitis	0.000204	0.000604	CcSEcCtD
Eprosartan—Body temperature increased—Betamethasone—ulcerative colitis	0.000204	0.000604	CcSEcCtD
Eprosartan—Abdominal pain—Betamethasone—ulcerative colitis	0.000204	0.000604	CcSEcCtD
Eprosartan—Abdominal pain—Dexamethasone—ulcerative colitis	0.000204	0.000604	CcSEcCtD
Eprosartan—Body temperature increased—Dexamethasone—ulcerative colitis	0.000204	0.000604	CcSEcCtD
Eprosartan—Asthenia—Methylprednisolone—ulcerative colitis	0.000204	0.000603	CcSEcCtD
Eprosartan—AGTR1—GPCR downstream signaling—CCL20—ulcerative colitis	0.000203	0.00361	CbGpPWpGaD
Eprosartan—Insomnia—Prednisone—ulcerative colitis	0.000203	0.000602	CcSEcCtD
Eprosartan—Paraesthesia—Prednisone—ulcerative colitis	0.000202	0.000597	CcSEcCtD
Eprosartan—AGTR1—GPCR ligand binding—ADRB2—ulcerative colitis	0.000201	0.00358	CbGpPWpGaD
Eprosartan—Pruritus—Triamcinolone—ulcerative colitis	0.000201	0.000595	CcSEcCtD
Eprosartan—Pruritus—Methylprednisolone—ulcerative colitis	0.000201	0.000594	CcSEcCtD
Eprosartan—Dizziness—Hydrocortisone—ulcerative colitis	0.0002	0.000591	CcSEcCtD
Eprosartan—Dyspepsia—Prednisone—ulcerative colitis	0.000198	0.000585	CcSEcCtD
Eprosartan—Decreased appetite—Prednisone—ulcerative colitis	0.000195	0.000578	CcSEcCtD
Eprosartan—Rash—Prednisolone—ulcerative colitis	0.000195	0.000577	CcSEcCtD
Eprosartan—Dermatitis—Prednisolone—ulcerative colitis	0.000195	0.000577	CcSEcCtD
Eprosartan—Diarrhoea—Methylprednisolone—ulcerative colitis	0.000194	0.000575	CcSEcCtD
Eprosartan—Fatigue—Prednisone—ulcerative colitis	0.000194	0.000573	CcSEcCtD
Eprosartan—Headache—Prednisolone—ulcerative colitis	0.000194	0.000573	CcSEcCtD
Eprosartan—Constipation—Prednisone—ulcerative colitis	0.000192	0.000569	CcSEcCtD
Eprosartan—Vomiting—Hydrocortisone—ulcerative colitis	0.000192	0.000568	CcSEcCtD
Eprosartan—AGTR1—GPCR downstream signaling—GNA12—ulcerative colitis	0.000191	0.0034	CbGpPWpGaD
Eprosartan—Rash—Hydrocortisone—ulcerative colitis	0.00019	0.000564	CcSEcCtD
Eprosartan—AGTR1—Peptide ligand-binding receptors—CXCL8—ulcerative colitis	0.00019	0.00338	CbGpPWpGaD
Eprosartan—Dermatitis—Hydrocortisone—ulcerative colitis	0.00019	0.000563	CcSEcCtD
Eprosartan—Headache—Hydrocortisone—ulcerative colitis	0.000189	0.00056	CcSEcCtD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—ulcerative colitis	0.000189	0.00336	CbGpPWpGaD
Eprosartan—Dizziness—Triamcinolone—ulcerative colitis	0.000188	0.000557	CcSEcCtD
Eprosartan—Dizziness—Methylprednisolone—ulcerative colitis	0.000188	0.000555	CcSEcCtD
Eprosartan—Feeling abnormal—Prednisone—ulcerative colitis	0.000185	0.000548	CcSEcCtD
Eprosartan—Asthenia—Betamethasone—ulcerative colitis	0.000185	0.000548	CcSEcCtD
Eprosartan—Asthenia—Dexamethasone—ulcerative colitis	0.000185	0.000548	CcSEcCtD
Eprosartan—AGTR1—Signaling by GPCR—CCL20—ulcerative colitis	0.000185	0.00328	CbGpPWpGaD
Eprosartan—Gastrointestinal pain—Prednisone—ulcerative colitis	0.000184	0.000544	CcSEcCtD
Eprosartan—Nausea—Prednisolone—ulcerative colitis	0.000184	0.000544	CcSEcCtD
Eprosartan—Pruritus—Dexamethasone—ulcerative colitis	0.000183	0.00054	CcSEcCtD
Eprosartan—Pruritus—Betamethasone—ulcerative colitis	0.000183	0.00054	CcSEcCtD
Eprosartan—AGTR1—GPCR downstream signaling—CXCR2—ulcerative colitis	0.000181	0.00322	CbGpPWpGaD
Eprosartan—Vomiting—Triamcinolone—ulcerative colitis	0.000181	0.000535	CcSEcCtD
Eprosartan—Vomiting—Methylprednisolone—ulcerative colitis	0.00018	0.000534	CcSEcCtD
Eprosartan—Nausea—Hydrocortisone—ulcerative colitis	0.000179	0.000531	CcSEcCtD
Eprosartan—Rash—Triamcinolone—ulcerative colitis	0.000179	0.000531	CcSEcCtD
Eprosartan—Dermatitis—Triamcinolone—ulcerative colitis	0.000179	0.00053	CcSEcCtD
Eprosartan—Rash—Methylprednisolone—ulcerative colitis	0.000179	0.00053	CcSEcCtD
Eprosartan—Dermatitis—Methylprednisolone—ulcerative colitis	0.000179	0.000529	CcSEcCtD
Eprosartan—Urticaria—Prednisone—ulcerative colitis	0.000179	0.000528	CcSEcCtD
Eprosartan—Headache—Triamcinolone—ulcerative colitis	0.000178	0.000527	CcSEcCtD
Eprosartan—Headache—Methylprednisolone—ulcerative colitis	0.000178	0.000526	CcSEcCtD
Eprosartan—Abdominal pain—Prednisone—ulcerative colitis	0.000178	0.000526	CcSEcCtD
Eprosartan—Body temperature increased—Prednisone—ulcerative colitis	0.000178	0.000526	CcSEcCtD
Eprosartan—Diarrhoea—Betamethasone—ulcerative colitis	0.000177	0.000523	CcSEcCtD
Eprosartan—Diarrhoea—Dexamethasone—ulcerative colitis	0.000177	0.000523	CcSEcCtD
Eprosartan—AGTR1—Signaling by GPCR—GNA12—ulcerative colitis	0.000174	0.00309	CbGpPWpGaD
Eprosartan—Dizziness—Betamethasone—ulcerative colitis	0.000171	0.000505	CcSEcCtD
Eprosartan—Dizziness—Dexamethasone—ulcerative colitis	0.000171	0.000505	CcSEcCtD
Eprosartan—AGTR1—GPCR downstream signaling—CCR6—ulcerative colitis	0.00017	0.00303	CbGpPWpGaD
Eprosartan—Nausea—Triamcinolone—ulcerative colitis	0.000169	0.0005	CcSEcCtD
Eprosartan—Nausea—Methylprednisolone—ulcerative colitis	0.000169	0.000499	CcSEcCtD
Eprosartan—Hypersensitivity—Prednisone—ulcerative colitis	0.000166	0.00049	CcSEcCtD
Eprosartan—AGTR1—Signaling by GPCR—CXCR2—ulcerative colitis	0.000165	0.00293	CbGpPWpGaD
Eprosartan—Vomiting—Dexamethasone—ulcerative colitis	0.000164	0.000486	CcSEcCtD
Eprosartan—Vomiting—Betamethasone—ulcerative colitis	0.000164	0.000486	CcSEcCtD
Eprosartan—Rash—Betamethasone—ulcerative colitis	0.000163	0.000482	CcSEcCtD
Eprosartan—Rash—Dexamethasone—ulcerative colitis	0.000163	0.000482	CcSEcCtD
Eprosartan—Dermatitis—Betamethasone—ulcerative colitis	0.000163	0.000481	CcSEcCtD
Eprosartan—Dermatitis—Dexamethasone—ulcerative colitis	0.000163	0.000481	CcSEcCtD
Eprosartan—Headache—Betamethasone—ulcerative colitis	0.000162	0.000478	CcSEcCtD
Eprosartan—Headache—Dexamethasone—ulcerative colitis	0.000162	0.000478	CcSEcCtD
Eprosartan—Asthenia—Prednisone—ulcerative colitis	0.000161	0.000477	CcSEcCtD
Eprosartan—Pruritus—Prednisone—ulcerative colitis	0.000159	0.000471	CcSEcCtD
Eprosartan—CYP2C9—Arachidonic acid metabolism—PTGS2—ulcerative colitis	0.000157	0.00278	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CCR6—ulcerative colitis	0.000155	0.00275	CbGpPWpGaD
Eprosartan—Diarrhoea—Prednisone—ulcerative colitis	0.000154	0.000455	CcSEcCtD
Eprosartan—ABCC2—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	0.000154	0.00273	CbGpPWpGaD
Eprosartan—Nausea—Betamethasone—ulcerative colitis	0.000153	0.000454	CcSEcCtD
Eprosartan—Nausea—Dexamethasone—ulcerative colitis	0.000153	0.000454	CcSEcCtD
Eprosartan—CYP2C9—Biological oxidations—PTGS1—ulcerative colitis	0.000152	0.0027	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—SEL1L—ulcerative colitis	0.000151	0.00268	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—PTGER4—ulcerative colitis	0.00015	0.00267	CbGpPWpGaD
Eprosartan—Dizziness—Prednisone—ulcerative colitis	0.000149	0.00044	CcSEcCtD
Eprosartan—Vomiting—Prednisone—ulcerative colitis	0.000143	0.000423	CcSEcCtD
Eprosartan—Rash—Prednisone—ulcerative colitis	0.000142	0.000419	CcSEcCtD
Eprosartan—Dermatitis—Prednisone—ulcerative colitis	0.000142	0.000419	CcSEcCtD
Eprosartan—Headache—Prednisone—ulcerative colitis	0.000141	0.000417	CcSEcCtD
Eprosartan—AGTR1—GPCR downstream signaling—GHRL—ulcerative colitis	0.000137	0.00244	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—PTGER4—ulcerative colitis	0.000136	0.00242	CbGpPWpGaD
Eprosartan—Nausea—Prednisone—ulcerative colitis	0.000133	0.000395	CcSEcCtD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	0.000128	0.00227	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—GHRL—ulcerative colitis	0.000125	0.00222	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CXCR1—ulcerative colitis	0.000124	0.00221	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CALM3—ulcerative colitis	0.000121	0.00215	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—ADRB2—ulcerative colitis	0.000114	0.00202	CbGpPWpGaD
Eprosartan—ABCC2—NRF2 pathway—TGFB1—ulcerative colitis	0.000109	0.00194	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CCL20—ulcerative colitis	0.000109	0.00194	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—ADRB2—ulcerative colitis	0.000103	0.00183	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—GNA12—ulcerative colitis	0.000103	0.00182	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CXCR2—ulcerative colitis	9.73e-05	0.00173	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—CXCL8—ulcerative colitis	9.72e-05	0.00173	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	9.68e-05	0.00172	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—ADCY5—ulcerative colitis	9.65e-05	0.00172	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CCR6—ulcerative colitis	9.14e-05	0.00162	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	8.85e-05	0.00157	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—ADCY5—ulcerative colitis	8.77e-05	0.00156	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—MAML2—ulcerative colitis	8.67e-05	0.00154	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	8.25e-05	0.00147	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PTGER4—ulcerative colitis	8.05e-05	0.00143	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—GHRL—ulcerative colitis	7.37e-05	0.00131	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CALM3—ulcerative colitis	7.14e-05	0.00127	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—RIPK2—ulcerative colitis	7.03e-05	0.00125	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CHP1—ulcerative colitis	6.23e-05	0.00111	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—ADRB2—ulcerative colitis	6.1e-05	0.00108	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—JAK2—ulcerative colitis	6.02e-05	0.00107	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	5.84e-05	0.00104	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—ALB—ulcerative colitis	5.54e-05	0.000983	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—CXCL8—ulcerative colitis	5.49e-05	0.000976	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—JAK2—ulcerative colitis	5.47e-05	0.000971	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—DLD—ulcerative colitis	5.38e-05	0.000955	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—IL2—ulcerative colitis	5.25e-05	0.000933	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—ADCY5—ulcerative colitis	5.18e-05	0.00092	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CXCL8—ulcerative colitis	4.99e-05	0.000886	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—IL2—ulcerative colitis	4.77e-05	0.000847	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—JAK2—ulcerative colitis	3.23e-05	0.000574	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—RELA—ulcerative colitis	3.13e-05	0.000556	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CXCL8—ulcerative colitis	2.95e-05	0.000524	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	2.84e-05	0.000505	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—IL2—ulcerative colitis	2.82e-05	0.0005	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—IL6—ulcerative colitis	2.8e-05	0.000498	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—MMP9—ulcerative colitis	2.67e-05	0.000474	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—NFKB1—ulcerative colitis	2.64e-05	0.000468	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PTGS1—ulcerative colitis	2.6e-05	0.000462	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	2.56e-05	0.000454	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—STAT3—ulcerative colitis	2.37e-05	0.000421	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CALM3—ulcerative colitis	2.34e-05	0.000416	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	2.24e-05	0.000397	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—TGFB1—ulcerative colitis	2.2e-05	0.00039	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ABCB1—ulcerative colitis	1.82e-05	0.000323	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—TP53—ulcerative colitis	1.81e-05	0.000321	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ADCY5—ulcerative colitis	1.7e-05	0.000302	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—IL6—ulcerative colitis	1.66e-05	0.000294	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PPARG—ulcerative colitis	1.27e-05	0.000225	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ALB—ulcerative colitis	1.14e-05	0.000202	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PTGS2—ulcerative colitis	9.96e-06	0.000177	CbGpPWpGaD
